20 likes | 34 Views
Real-world evidence (RWE) is used in an exponential way to guide payment decisions and access systems for patients and help clinical decision-making in conditions such as cancer characterized by heterogeneous patient groups and different care routes. In the world of cancer diagnostics, RWE draws from a range of sources, including electronic health reports, customer data, payer claims databases, patient registries, and others, allowing innovators to explain how a product can work over some time within a larger, more representative population. This approach to evidence generation is of great concern to payers, as they increasingly rely on RWE to make decisions on coverage and reimbursement.<br><br>https://www.delveinsight.com/whitepaper-newsletter/real-world-evidence-diagnostics-in-cancer
E N D
1 The Real The Real- -World Evidence Whitepaper World Evidence Whitepaper Real-world evidence (RWE) is used in an exponential way to guide payment decisions and access systems for #patients and help #clinical decision-making in conditions such as cancer characterized by heterogeneous patient groups and different care routes. In the world of cancer #diagnostics, RWE draws from a range of sources, including electronic health #reports, customer #data, payer #claims databases, patient registries, and others, allowing
2 innovators to explain how a product can work over sometime within a larger, more representative population. Interest in real-world evidence in the pharmaceutical industry continues to grow due to regulatory opportunities and payer demands. Want to learn more about the need and importance of Real-world evidence in today’s cancer diagnostics era? Access here for free:- https://lnkd.in/gQpCVFP Source:- https://www.delveinsight.com/whitepaper-newsletter/real-world-evidence- diagnostics-in-cancer #healthcare#digitalhealth#healthtech#medtech#clinicaltrials#medicaldevices#research#bi otech#data#health#opportunities#pharmaceuticalindustry#diagnostics#cancer#medicine #work